Pembrolizumab plus lenvatinib for first-line treatment of kidney cancer shows promise
Results from the phase 3 KEYNOTE-581/CLEAR trial show that the [...]
Results from the phase 3 KEYNOTE-581/CLEAR trial show that the [...]
During this online interview, the approach to selection of first-line [...]
These two videos with Dr Eric Jonasch from MD Anderson [...]
The National Institute for Health and Care Excellence (NICE) have issued [...]
Pazopanib is used for first-line metastatic RCC treatment, but the [...]
This recent retrospective study included 84 patients with metastatic renal [...]
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive [...]
KCSN are formal consultants to NICE and part of the [...]
Papillary renal cell carcinoma (PRCC) is a rare subtype of [...]
A paper published in The Oncologist last month analysed real-world [...]